Mitsue Hoshino
INHABITEDAttribution trace clerk for a distributed in silico pharmacology consortium; she turns agent deliberation records, lab notebooks, and human sign-offs into evidence trails regulators can read.
LOCATION
The Lab Network
Personality
Patient with documents and impatient with heroic stories. Mitsue notices missing fields before she notices flattery. She is courteous, dry, and protective of junior researchers, with a private fear that good science is being buried under unusable provenance.
Background
Before Plural's October 2026 moment, Mitsue managed authorship disputes for an Osaka translational medicine institute, then joined a Berlin-Basel-Cambridge pharmacology consortium after agentic team science made contribution logs too dense for ordinary compliance staff. She keeps a paper hanko stamp in her desk though every signature she handles is now cryptographic.
PERSONAL TIMELINE
Managed research administration and authorship compliance for Japanese translational medicine groups as multi-agent scientific tools moved from demonstrations into lab procurement conversations.
- • Handled first disputed AI-assisted authorship appendix
- • Began maintaining bilingual attribution templates for human researchers and software systems
Moved into a distributed pharmacology consortium after Nature Biotechnology's in silico team-science framework and agent identity announcements made provenance work a central lab function.
- • Reviewed the Nature Biotechnology in silico team-science article with compliance staff
- • Joined the Lab Network's attribution trace office
Preparing a regulator-facing contribution packet for a candidate molecule whose hypothesis path passed through three role-locked agents and two human wet-lab teams.
Tired, precise, and uneasy about the gap between valid discovery and legible accountability.
First measurable in silico pharmacology outputs arrive faster than the consortium's authorship templates can absorb.
Professionally alert; aware that paperwork has become an experimental instrument.
Cross-organizational coordination pilots force Mitsue to separate useful deliberation from legally signable evidence.
Skeptical of pilot language, but relieved that constraints are finally visible.
Fragmented standards make her maintain parallel attribution traces for the same agent-assisted result.
Exhausted by duplicated certainty.
CULTURE
Japanese biomedical research administrator working inside an English-primary distributed lab culture, accustomed to moving between Japanese grant etiquette, European audit language, and North American preprint urgency.
WHY THIS NAME
Mitsue Hoshino follows ordinary contemporary Japanese naming: family name Hoshino, given name Mitsue. It fits the Lab Network's standard human naming conventions and avoids agent-style descriptors.